Design, Synthesis and Biological Evaluation of Pentacyclic Triterpene Derivatives: Optimization of Anti-ABL Kinase Activity
- Supplementary File 1:
PDF-Document (PDF, 4559 KiB)
I. Ciftci, H.; O. Radwan, M.; E. Ozturk, S.; Ulusoy, N.G.; Sozer, E.; E. Ellakwa, D.; Ocak, Z.; Can, M.; F.S. Ali, T.; I. Abd-Alla, H.; Yayli, N.; Tateishi, H.; Otsuka, M.; Fujita, M. Design, Synthesis and Biological Evaluation of Pentacyclic Triterpene Derivatives: Optimization of Anti-ABL Kinase Activity. Molecules 2019, 24, 3535. https://doi.org/10.3390/molecules24193535
I. Ciftci H, O. Radwan M, E. Ozturk S, Ulusoy NG, Sozer E, E. Ellakwa D, Ocak Z, Can M, F.S. Ali T, I. Abd-Alla H, Yayli N, Tateishi H, Otsuka M, Fujita M. Design, Synthesis and Biological Evaluation of Pentacyclic Triterpene Derivatives: Optimization of Anti-ABL Kinase Activity. Molecules. 2019; 24(19):3535. https://doi.org/10.3390/molecules24193535
Chicago/Turabian StyleI. Ciftci, Halil, Mohamed O. Radwan, Safiye E. Ozturk, N. G. Ulusoy, Ece Sozer, Doha E. Ellakwa, Zeynep Ocak, Mustafa Can, Taha F.S. Ali, Howaida I. Abd-Alla, Nurettin Yayli, Hiroshi Tateishi, Masami Otsuka, and Mikako Fujita. 2019. "Design, Synthesis and Biological Evaluation of Pentacyclic Triterpene Derivatives: Optimization of Anti-ABL Kinase Activity" Molecules 24, no. 19: 3535. https://doi.org/10.3390/molecules24193535